<?xml version="1.0" encoding="UTF-8"?>
<p id="p0240">Whatever is the actual cause of the progressive reduction of 27OHC in the course of COVID-19, this observational clinical study definitely suggests the opportunity of counteracting such an event, in order to reinforce or reintegrate the antiviral defence system with the administration of suitably formulated 27OHC endowed with antiviral activity.</p>
